Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 9 de 9
Filter
1.
Eur Child Adolesc Psychiatry ; 26(5): 603-617, 2017 May.
Article in English | MEDLINE | ID: mdl-27942998

ABSTRACT

Our objectives were to assess health-related quality of life (HRQoL), anxiety, depression of Gilles de la Tourette syndrome (GTS) adolescents' parents compared to controls; to assess GTS adolescents' HRQoL compared to controls; to investigate which parental and adolescent variables are associated with poorer parental HRQoL. The controlled study involved GTS outpatients and their parents, adolescent healthy controls matched for gender and age and their parents. Parents' HRQoL was assessed using SF-36 and WHOQOL-BREF; anxiety, depression using HADS. Adolescents' HRQoL was assessed by adolescents using VSP-A instrument and by their parents using VSP-P. A total of 75 GTS adolescents, 75 mothers, 63 fathers were compared to 75 control adolescents, 75 mothers, 62 fathers. GTS mothers had worse HRQoL than controls on 5 of the 8 SF-36 dimensions and 1 of the 4 WHOQOL-BREF dimensions, while GTS fathers had worse HRQoL on 2 of the WHOQOL-BREF dimensions. GTS mothers had poorer HRQoL than fathers. GTS mothers had more depression than control mothers and GTS fathers had more anxiety than control fathers. GTS adolescents had worse HRQoL than controls on 5 of the 9 VSP-A dimensions. Factors significantly related to parental HRQoL were anxiety, depression, GTS adolescents' HRQoL and, concerning mothers, behavioural and emotional adolescents' problems; concerning fathers, severity of vocal tics, duration since first symptoms. This study provides a better understanding of poorer HRQoL and psychiatric morbidity of GTS adolescents' parents. Clinicians should pay attention to their emotional well-being and HRQoL and be aware that mothers and fathers are differently affected.


Subject(s)
Anxiety/psychology , Depression/psychology , Parents/psychology , Quality of Life/psychology , Tourette Syndrome/diagnosis , Adolescent , Adult , Anxiety/epidemiology , Case-Control Studies , Depression/epidemiology , Female , Health Status , Humans , Male , Mental Health , Middle Aged , Outcome Assessment, Health Care , Psychiatric Status Rating Scales , Surveys and Questionnaires , Tics/psychology , Tourette Syndrome/psychology
2.
Oral Dis ; 23(3): 300-311, 2017 Apr.
Article in English | MEDLINE | ID: mdl-26945691

ABSTRACT

Regeneration of periodontal tissues is one of the main goals of periodontal therapy. However, current treatment, including surgical approach, use of membrane to allow maturation of all periodontal tissues, or use of enamel matrix derivatives, presents limitations in their indications and outcomes leading to the development of new tissue engineering strategies. Several cytokines are considered as key molecules during periodontal destruction process. However, their role during each phase of periodontal wound healing remains unclear. Control and modulation of the inflammatory response and especially, release of cytokines or activation/inhibition in a time- and spatial-controlled manner may be a potential perspective for periodontal tissue engineering. The aim of this review was to summarize the specific role of several cytokines during periodontal wound healing and the potential therapeutic interest of inflammatory modulation for periodontal regeneration especially related to the expression sequence of cytokines.


Subject(s)
Cytokines , Inflammation/drug therapy , Periodontium/physiology , Wound Healing , Anti-Bacterial Agents/therapeutic use , Anti-Inflammatory Agents, Non-Steroidal/therapeutic use , Biological Products/therapeutic use , Cell Proliferation , Cytokines/antagonists & inhibitors , Guided Tissue Regeneration, Periodontal , Humans , Inflammation/metabolism , Regeneration
3.
Qual Life Res ; 22(3): 509-20, 2013 Apr.
Article in English | MEDLINE | ID: mdl-22476573

ABSTRACT

PURPOSE: To cross-culturally adapt a French version of the LEIPAD, a self-administered questionnaire assessing the health-related quality of life (HRQoL) in adults aged 65 years and over living at home, and to evaluate its psychometric properties. METHODS: After having translated LEIPAD in accordance with guidelines, we studied psychometric properties: reliability and construct validity-factor analysis, relationships between items and scales, internal consistency, concurrent validity with the Medical Outcome Study Short-Form 36 and known-groups validity. RESULTS: The results obtained in a sample of 195 elderly from the general population showed very good acceptability, with response rates superior to 93 %. Exploratory factor analysis extracted eight factors providing a multidimensionality structure with five misclassifications of items in the seven theoretical scales. Good internal consistency (Cronbach's alpha ranging from 0.73 and 0.86) and strong test-retest reliability (ICCs higher than 0.80 for six scales and 0.70 for one) were demonstrated. Concurrent validity with the SF-36 showed small to strong expected correlations. CONCLUSION: This first evaluation of the French version of LEIPAD's psychometric properties provides evidence in construct validity and reliability. It would allow HRQoL assessment in clinical and common practice, and investigators would be able to take part in national and international research projects.


Subject(s)
Health Status , Outcome Assessment, Health Care , Psychometrics/instrumentation , Quality of Life , Surveys and Questionnaires , Aged , Aged, 80 and over , Cross-Cultural Comparison , Culture , Factor Analysis, Statistical , Female , Humans , Language , Male , Psychometrics/statistics & numerical data , Reproducibility of Results , Socioeconomic Factors , Translating
4.
Neurology ; 68(17): 1345-55, 2007 Apr 24.
Article in English | MEDLINE | ID: mdl-17452578

ABSTRACT

OBJECTIVE: To assess the role of age in the results of bilateral deep brain stimulation in the subthalamic nucleus (DBS-STN), we carried out a study of two groups of patients regarding age at time of surgery. METHODS: We compared, up to 2 years after surgery, the clinical effects, safety, and quality of life in parkinsonian patients younger than 65 years old (young patients) vs parkinsonian patients 65 years old or older (old patients). RESULTS: The mean age was 57.4 +/- 4.9 years (n = 53) in young patients and 68.8 +/- 2.8 years (n = 34) in old patients. A dramatic improvement in motor complications was equally observed in both groups of patients. There was no significant difference between the groups regarding acute effects of DBS-STN on the motor score of the Unified Parkinson's Disease Rating Scale part III (UPDRS III). Time course evolution of UPDRS the motor score (p < 0.0001) and axial score (p = 0.0001) assessed postoperatively in "on" medication and "on" stimulation conditions appeared worse in old patients as compared to young patients. Improvement in the Schwab and England Scale score was better in young patients in "on" (p < 0.0003) and "off" state (p < 0.001). Quality of life assessed with the 39-item Parkinson's Disease Questionnaire showed an improvement in subscales evaluating mobility (p < 0.0001), activities of daily life (p < 0.0001), emotion and stigma (p = 0.0004), cognition (p < 0.0074), and communication (p = 0.0029) in young patients as compared to old patients. Side effects were similar in the two groups. CONCLUSIONS: Although deep brain stimulation in the subthalamic nucleus reduces motor complications equally in both groups of patients, postoperative quality of life improved only in young patients.


Subject(s)
Deep Brain Stimulation , Parkinson Disease/therapy , Subthalamic Nucleus/physiopathology , Activities of Daily Living , Age Factors , Aged , Antiparkinson Agents/therapeutic use , Bipolar Disorder/etiology , Catechols/therapeutic use , Cognition , Combined Modality Therapy , Communication , Deep Brain Stimulation/adverse effects , Dysarthria/etiology , Electrodes, Implanted/adverse effects , Emotions , Female , Humans , Levodopa/therapeutic use , Male , Middle Aged , Movement , Neuropsychological Tests , Nitriles/therapeutic use , Parkinson Disease/drug therapy , Parkinson Disease/psychology , Pergolide/therapeutic use , Prejudice , Quality of Life , Severity of Illness Index , Subthalamic Nucleus/injuries , Treatment Outcome , Weight Gain
5.
Neurology ; 62(3): 381-8, 2004 Feb 10.
Article in English | MEDLINE | ID: mdl-14872017

ABSTRACT

OBJECTIVE: To investigate the efficacy and safety of clozapine in the treatment of levodopa-induced dyskinesias (LID) in patients with severe Parkinson disease (PD). METHODS: Fifty patients were randomized to treatment in this 10-week, double-blind, parallel-group, placebo-controlled, multicenter trial. The principal measure of outcome was the diurnal change in the "on" time with LID assessed using a self-evaluation of the motor performance fluctuations performed every 2 weeks. An acute levodopa challenge was also performed at the beginning and end of the study. RESULTS: A reduction in the duration of "on" periods with LID was noted in favor of the clozapine group at the end of the study (placebo group day 0: 4.54 +/- 0.53 hours, end: 5.28 +/- 0.70 hours; clozapine group day 0: 5.68 +/- 0.66 hours, end: 3.98 +/- 0.57 hours; p = 0.003). The mean clozapine dosage was 39.4 +/- 4.5 (SEM) mg/day. The maximal LID score at rest during the levodopa challenge was significantly decreased under clozapine treatment, with a variation from day 0 to day 70 in the placebo group of +0.15 +/- 1.01 and in the clozapine group of -2.22 +/- 0.52 (p < 0.05). Five patients receiving clozapine and seven receiving placebo discontinued on account of adverse events. Among them, three patients in the clozapine group developed eosinophilia, which rapidly resolved after withdrawal of the drug. CONCLUSION: Clozapine is effective in the treatment of levodopa-induced dyskinesias in severe PD.


Subject(s)
Antiparkinson Agents/adverse effects , Clozapine/therapeutic use , Dyskinesia, Drug-Induced/drug therapy , Parkinson Disease/complications , Aged , Antiparkinson Agents/therapeutic use , Double-Blind Method , Dyskinesia, Drug-Induced/etiology , Humans , Levodopa/adverse effects , Levodopa/therapeutic use , Middle Aged , Parkinson Disease/drug therapy , Serotonin Receptor Agonists/therapeutic use , Treatment Outcome
6.
Psychol Rep ; 84(2): 643-9, 1999 Apr.
Article in English | MEDLINE | ID: mdl-10335078

ABSTRACT

Studies examining the link between family size and intelligence have consistently found a negative relationship. Children born into larger families tend to score lower on intelligence tests than children raised in smaller families. One recurrent but unexplained finding is that the relation between intelligence and number of siblings is consistently significant for verbal intelligence but inconsistent for nonverbal intelligence. Here, we conceptualize emotional intelligence as one facet of nonverbal intelligence. The research develops a measure of emotional intelligence and uses it to test the hypothesis that emotional intelligence is positively correlated with family size. The results, based upon a sample of graduate students, support the hypothesized relationship. Implications for the study of family size and intelligence, for refining the conceptualizations and measures of nonverbal intelligence, and for leadership theory, are discussed.


Subject(s)
Affect , Family Characteristics , Intelligence , Adult , Female , Humans , Male
8.
Rev Odontostomatol (Paris) ; 18(3): 201-10, 1989.
Article in French | MEDLINE | ID: mdl-2633270

ABSTRACT

1,247 avulsions have been noted for a year in the S.C.T.D. (tooth, age and sex of the patient). 44.6% were caused by tooth decay. However periodontal disease was responsible for 39.5% of tooth avulsions. The tooth lost because of periodontal disease were in most part extracted after 40 years. A weakness of some type of teeth regarding tooth mortality may be quoted. A sexual dimorphism of tooth mortality was present in the studied population.


Subject(s)
Periodontal Diseases/complications , Tooth Exfoliation/etiology , Adolescent , Adult , Age Factors , Aged , Dental Caries/complications , Female , Humans , Male , Middle Aged , Sex Factors
9.
Appl Opt ; 9(10): 2305, 1970 Oct 01.
Article in English | MEDLINE | ID: mdl-20094254

ABSTRACT

This paper describes a narrow bandpass filter which is temperature controlled to maintain optical characteristic while operating in an ambient temperature range of -20 degrees C to +70 degrees C. Pertinent source of bandpass shift and means for their control are discussed. The analytical approach, resultant filter assembly configuration, and performance test results of the assembly are presented.

SELECTION OF CITATIONS
SEARCH DETAIL
...